In the health sector the realization of globalization of markets is already well advanced. Great effort is being made to harmonize research guidelines, requirements for registration data and health politics. Mega mergers of pharmaceutical companies are simultaneously the result and accelerator of this development. Associated with these processes, we recognize an enormous change within the institutions of the health care system and the pharmaceutical industry. In order to meet the challenges of this process in Europe as well, it is necessary to build up an innovative education concept for people able to fulfill the demands of the future. Perceiving this situation the curriculum for the postgraduate study course Pharmaceutical Medicine was developed and after approval implemented.
The international orientated study course Master of Science (MSc) in Pharmaceutical Medicine at the University of Duisburg-Essen is the first accredited and state-approved Postgraduate Study Course in Pharmaceutical Medicine in Germany. We are establishing a unique educational concept based on a novel style of academic training combined with real life case studies, role plays and applied medicine. Participants will interact with lecturers from Austria, Belgium, France, Germany, Spain, Switzerland, the UK and the USA. They are key thought and opinion leaders. They work in health care institutions and the international pharmaceutical industry.
Job description and job opportunities
The English study course is designed that it can be conducted while the participant is working. This opens especially employees of pharmaceutical companies and health care institutions job-related options. While observing national and international quality standards, Pharmaceutical Medicine deals with the discovery, research and development of medicinal products and medical devices. In addition, it is engaged in benefit/risk-assessment, approval, marketing and monitoring of drugs and biotechnological products.
The objective of this study course is to focus on day-to-day practice, to promote interdisciplinary knowledge and to enable the participants to deal with the complex international tasks facing health care institutions and the pharmaceutical industry. We are offering the leading European study course in pharmaceutical medicine and creating a rich international educational environment. Our vision is to develop the next generation of leaders for health care institutions and the pharmaceutical industry, with a broad understanding of managing changes, innovations and new product development.
The study course covers two years and is divided into 12 modules with 19 study units taught in block seminars on Thursday afternoon, Friday and Saturday at the University of Duisburg-Essen. Each study unit concludes with an examination. After 19 study units, a time period for thesis preparation and oral examination follows.
General Introduction to the Health System and the Pharmaceutical Industry
Core Competencies: Leadership, Management Methods, Organizational Power
- Working in a Complex Organization
- Project Management
Economics of Healthcare
- Health Economics
- International Health Systems and Market Access
- Drug Discovery and Development
- Biopharmaceuticals and –technology
Non-Clinical Testing, Pharmaceutical and Early Clinical Development
- Clinical Pharmacology, Pharmacokinetics
Clinical Trials, Strategies and Management
- Clinical Trials
- Strategies and Managing Clinical Trials
Ethical and Legal Issues in Drug Development
Data Management and Statistics
- Clinical Systems and Data Management
Drug Safety and Pharmacovigilance
- Drug Safety
- Post-Marketing Surveillance
- Marketing and Sales
Pharmaceutical Related Case Studies
Final Oral Examination
Candidates must hold a degree in one of the following disciplines: Natural sciences (e.g. life sciences, pharmaceutical sciences) medicine, pharmacy as well as one year professional experience and good English language skills.
Only send copies of certificates. Due to data protection reasons your documents will be destroyed after all admission procedures have been completed. Originals are only needed when registering at the university.
The best qualified applicants will be invited to participate in an intensive interviewing process, designed to assess their motivation, social competence, level of commitment, and to confirm their basic knowledge of the field.
The total course fee is currently € 14.850,- ( € 7425,- per year). The fee includes the costs for the final examination. Individuals do have the possibility to make an application for financial support
The general objectives of this course are
- to give the participant an integrated overview of all relevant topics within
the health institutions and the pharmaceutical industry.
- to educate physicians and scientists in all major aspects of drug research
and development, with emphasis on clinical development.
- to stimulate an insight into the pitfalls and possibilities of research and
development with a new chemical entity.
- to present the health economic environment and its implications for drug
- to create an educational platform that enables the participant to fulfil and
understand a variety of roles within the health institutions and the
- to make the participant aware of various aspects of social competence as well as of the scientific, ethical and social role of the clinical scientist in professional teams within the health institutions and the pharmaceutical industry.
- to train the participant in moderation and leadership of groups.
- to increase the communicative skills of the candidate.
For each study unit the participant has one month preparation time based on a given "Reader", which contains basic and additional information and tasks about the topic to be taught and discussed during the block seminar. The participant studies the "Reader" and becomes a "junior expert". During the block seminar the "junior expert" (participant) would meet the "senior experts" (lecturing team) to ask, to discuss and to demonstrate his knowledge on a scientific basis.
The main emphasis of the study course is teamwork, along with participants presentations and discussions to teach the ability in competent management. Classic lectures will be given only for the introduction of a topic, to present basic knowledge and fundamental theories.
Course language is English.
The study units are held at the University of Duisburg-Essen, Faculty of Medicine, Germany.
Institute for Education in Pharmaceutical Medicine (PME)
The Institute for Education in Pharmaceutical Medicine (PME) was founded in 2005 with the task of combining a university's hands-on oriented education with an innovative, onthe-job professional training for committed scientists and health care professionals. PME is responsible for the organization and the implementation of the study units. It is the central interface which builds the connecting link for all persons involved.
PME Institute for Education in Pharmaceutical Medicine